Viewing StudyNCT00258050



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00258050
Status: COMPLETED
Last Update Posted: 2017-12-06
First Post: 2005-11-22

Brief Title: To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Neoplasms Breast
Keywords:
Name View
lapatinib View
midazolam View
pharmacokinetics View